Theravance Biopharma Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
9.90
-0.09
(-0.9%)
Volume:
342,990
52 week range:
7.44 - 10.90
Market Cap:
489.759M
Company Description:
Theravance Biopharma, Inc. discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD) Its product portfolio also include Izencitinib, a gut-selective pan-janus kinase (JAK) inhibitor.